Programming - Vascular Discovery: from Genes to Medicine Scientific Sessions 2021

2021 Preliminary Program

This section will be updated as speakers and presentations are confirmed. For a printable document, see the 2021 Schedule at a Glance (PDF)

Wednesday

Time (Central Daylight Time)
Event
8:30 – 8:45 a.m.

Conference Preview, Coffee with the Chairs

  • Lars Maegdefessel, MD, PhD, Technical University Munich, Munich, Germany
     
  • Katey Rayner, PhD, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
8:45 – 9:00 a.m.

Conference Opening Welcome

9:00 – 10:20 a.m.

Plenary Session I: Vascular Complications of COVID-19

  • 9:00 – Innate and Adaptive Immune Regulation of Thrombosis in COVID-19, Yogen Kanthi, MD, NIH/NHLBI, Bethesda, Maryland
     
  • 9:20 – Title TBD, Anna Randi, MD, PhD, National Heart and Lung Institute, Imperial College, London, United Kingdom
     
  • 9:40 – Title TBD, Clyde W. Yancy, MD, MSc, Northwestern University Feinberg School of Medicine, Chicago, Illinois
     
  • 10:00 – Post-session Discussion/Q&A
     
10:20 – 10:30 a.m.

Break + Exhibits

10:30 – 11:50 a.m.

Concurrent Sessions

  • 1 A: Highlights from the ATVB Journal
     
  • 1 B: Oral Abstract Presentations TBA
     
  • 1 C: Oral Abstract Presentations TBA
     
11:50 a.m. – Noon

Break + Exhibits

Noon – 1:00 p.m.

Mentor of Women Award and Featured Presentation

1:00 – 2:00 p.m.

Moderated Poster Sessions and ePoster Viewing

2:00 – 3:00 p.m.

Early Career Training Session

3:00 – 4:00 p.m.

Networking, Award Presentations and Recognition, Industry Events

Thursday

Time (Central Daylight Time)
Event
9:00 – 10:20 a.m.

Plenary Session II: Novel Concepts of Atherosclerosis

  • 9:00 – Clonal Hematopoiesis and Cardiovascular Disease, Benjamin L. Ebert, MD, PhD, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts
     
  • 9:20 – Genetic Discovery in Trans-ethnic Cohorts for Blood Lipid Levels and Implications for Polygenic Score Development: From the Global Lipids Genetics Consortium, Cristen Willer, PhD, University of Michigan Medical School, Ann Arbor, Michigan
     
  • 9:40 – A Translational Brake on Cholesterol Efflux and Efferocytosis Drives Atherosclerotic Progression, Ebru Erbay, MD, PhD, Cedars-Sinai Medical Center, Los Angeles, California
     
  • 10:00 – Post-session Discussion/Q&A
10:20 – 10:30 a.m.

Break + Exhibits

10:30 – 11:50 a.m.

Concurrent Sessions

  • 2 A: Brinkhous Prize Competition
     
  • 2 B: Page Award Competition
     
  • 2 C: Oral Abstract Presentations TBA
11:50 a.m. – Noon

Break + Exhibits

Noon – 1:00 p.m.

Next Generation Technology Bootcamp

1:00 – 2:00 p.m.

Moderated Poster Sessions and ePoster viewing

2:00 – 3:00 p.m.

Early Career Training Session

3:00 – 4:00 p.m.

Networking, Award Presentations and Recognition, Industry Events

Friday

Time (Central Daylight Time)
Event
9:00 – 10:20 a.m.

Plenary Session III: Invited Lecture Series

  • 9:00 – Hoeg Award Lecture - TBA
     
  • 9:20 – Distinguished Lecture – Converging Pathways in Pulmonary Vascular Pathobiology – Marlene Rabinovitch, MD, Stanford University School of Medicine, Stanford, California
     
  • 9:40 – Keynote Lecture – Polygenic Scores: Potential for Clinical Utility and Therapeutic Target Identification – Michael Inouye, PhD, University of Cambridge, Strangeways Research Labs, Cambridge, United Kingdom
     
  • 10:00 – Post-session Discussion/Q&A
     
10:20 – 10:30 a.m.

Break + Exhibits

10:30 – 11:50 a.m.

Concurrent Sessions

  • 3 A: Oral Abstract Presentations TBA
     
  • 3 B: Oral Abstract Presentations TBA
     
  • 3 C: Oral Abstract Presentations TBA
     
11:50 a.m. – Noon

Break + Exhibits

Noon – 1:00 p.m.

Next Generation Technology Bootcamp

1:00 – 2:00 p.m.

Moderated Poster Sessions and ePoster viewing

2:00 – 3:00 p.m.

Early Career Training Session

3:00 – 4:00 p.m.

Networking, Award Presentations and Recognition

Target Audience

The conference will especially appeal to:

  • Basic scientists
  • Translational and clinical investigators
  • Clinicians interested in:
Target Audience
Vascular Health Vascular Medicine
Atherosclerosis Vascular Biology
Thrombosis Vascular surgery
Thromboembolism Peripheral artery disease
Molecular/cellular biology Functional genomics

About this Meeting

Vascular Discovery: From Genes to Medicine is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology and the Peripheral Vascular Disease Council, in cooperation with the Council on Genomic and Precision Medicine, and the Society for Vascular Surgery. The primary goal of this virtual event is to provide a forum for the exchange of information about new and emerging scientific research in lipids and lipoproteins, arteriosclerosis, thrombosis, vascular biology, genomics and peripheral vascular disease.

The format of the event, with many invited presentations as well as a dedicated focus on poster presentations, is intended to maximize a thought-provoking flow of information and discourse among scientists.

Learning Objectives

At the conclusion of this conference, participants will be able to:

  1. Discuss current guidelines for the use of prophylactic thrombolysis in the inpatient setting and identify performance improvement approaches to improve adherence.
  2. Discuss current research and findings into the molecular and genetic underpinnings of atherosclerotic disease and the implications for clinical practice.
  3. Discuss current guidelines for the appropriate management of PAD and opportunities to improve their use in clinical practice.
  4. Describe the role and potential role of emerging treatments for dyslipidemia.

Abstract Submission
Abstract submissions are closed